Ablation of AMP-activated Protein Kinase α2 Activity Exacerbates Insulin Resistance Induced by High-fat Feeding of Mice
- Nobuharu Fujii, PhD1,
- Richard C. Ho, PhD1,
- Yasuko Manabe, PhD1,
- Niels Jessen, M.D1,
- Taro Toyoda, PhD1,
- William L. Holland, PhD2,
- Scott A. Summers, PhD2,
- Michael F. Hirshman, B.S1 and
- Laurie J. Goodyear, PhD (laurie.goodyear{at}joslin.harvard.edu)1
- 1Research Division, Joslin Diabetes Center and Department Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
- 2Division of Endocrinology, Diabetes, and Metabolism, University of Utah School of Medicine, Salt Lake City, UT
Abstract
Objective: We determined if muscle AMP-activated protein kinase (AMPK) has a role in the development of insulin resistance.
Research Design And Methods: Muscle-specific transgenic mice expressing an inactive form of the AMPK α2 catalytic subunit (α2i TG) and their wild type littermates were fed either a high-fat (60% kcal fat) or a control diet (10% kcal fat) for 30 weeks.
Results: Compared with wild type mice, glucose tolerance in α2i TG mice was slightly impaired on the control diet, and significantly impaired on the high-fat diet. To determine whether the whole body glucose intolerance was associated with impaired insulin sensitivity in skeletal muscle, glucose transport in response to submaximal insulin (450 μU/ml) was measured in isolated soleus muscles. On the control diet, insulin-stimulated glucose transport was reduced by approximately 50% in α2i TG mice compared with wild type mice. High fat feeding partially decreased insulin-stimulated glucose transport in wild type mice, while the high fat feeding resulted in a full blunting of insulin-stimulated glucose transport in the α2iTG mice. High fat feeding in α2i TG mice was accompanied by decreased expression of insulin signaling proteins in gastrocnemius muscle.
Conclusions: The lack of skeletal muscle AMPK α2 activity exacerbates the development of glucose intolerance and insulin resistance caused by high-fat feeding, and supports the thesis that AMPK α2 is an important target for the prevention/amelioration of skeletal muscle insulin resistance through lifestyle (exercise) and pharmacologic (e.g. metformin) treatments.
Footnotes
-
- Received August 23, 2007.
- Accepted August 16, 2008.
- Copyright © American Diabetes Association














